Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression

被引:264
|
作者
Ohl, Kim [1 ]
Tenbrock, Klaus [1 ]
机构
[1] Rhein Westfal TH Aachen, Med Fac, Dept Pediat, Aachen, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
关键词
ROS; MDSC; Nrf2; redox regulation; metabolism; B-CELL RESPONSES; TUMOR-BEARING HOST; OXIDATIVE STRESS; T-CELLS; CANCER-PATIENTS; MYELOID CELLS; IN-VITRO; MECHANISM; DIFFERENTIATION; MITOCHONDRIA;
D O I
10.3389/fimmu.2018.02499
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reactive oxygen species (ROS) molecules are implicated in signal transduction pathways and thereby control a range of biological activities. Immune cells are constantly confronted with ROS molecules under both physiologic and pathogenic conditions. Myeloid-derived suppressor cells (MDSCs) are immunosuppressive, immature myeloid cells and serve as major regulators of pathogenic and inflammatory immune responses. In addition to their own release of ROS, MDSCs often arise in oxidative-stress prone environments such as in tumors or during inflammation and infection. This evidently close relationship between MDSCs and ROS prompted us to summarize what is currently known about ROS signaling within MDSCs and to elucidate how MDSCs use ROS to modulate other immune cells. ROS not only activate anti-oxidative pathways but also induce transcriptional programs that regulate the fate and function of MDSCs. Furthermore, MDSCs release ROS molecules as part of a major mechanism to suppress T cell responses. Targeting redox-regulation of MDSCs thus presents a promising approach to cancer therapy and the role of redox-signaling in MDSCs in other disease states such as infection, inflammation and autoimmunity would appear to be well worth investigating.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Negative roles of C/EBPα in MDSC-mediated tumor angiogenesis and immune suppression
    Qu, Peng
    Min, Yongfen
    Yang, Li
    Lin, Charles
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Highlights on Molecular Mechanisms of MDSC-Mediated Immune Suppression: Paving the Way for New Working Hypotheses
    Solito, Samantha
    Pinton, Laura
    Damuzzo, Vera
    Mandruzzato, Susanna
    IMMUNOLOGICAL INVESTIGATIONS, 2012, 41 (6-7) : 722 - 737
  • [3] Inhibition of HMGB1 delays tumor progression, reduces MDSC-mediated immune suppression, and diminishes MDSC-macrophage cross-talk
    Parker, Katherine
    Horn, Lucas
    Clements, Virginia
    Sinha, Pratima
    Yang, Huan
    Li, Jianhua
    Tracey, Kevin
    Ostrand-Rosenberg, Suzanne
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [4] MyD88-stimulated T cells acquire resistance to MDSC-mediated suppression
    Ciavattone, Nicholas G.
    Parker, Dominique
    Joseph, Ann Mary
    Davila, Eduardo
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [5] Role of reactive oxygen species in immune suppression in cancer
    Corzo, Cesar Alexander
    Nagaraj, Srinivas
    Kusmartsev, Sergei
    Gabrilovich, Dmitry
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S277 - S277
  • [6] Role of reactive oxygen species in immune suppression in cancer
    Corzo, Cesar Alexander
    Nagaraj, Srinivas
    Kusmartsev, Sergei
    Gabrilovich, Dmitry
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [7] Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
    Deng, Yayuan
    Shi, Mengjia
    Yi, Lin
    Khan, Muhammad Naveed
    Xia, Zhijia
    Li, Xiaosong
    HELIYON, 2024, 10 (17)
  • [8] TAM RTKs facilitate MDSC-mediated tumor immunosuppression
    Holtzhausen, Alisha
    Harris, William
    Hunter, Debra
    Ubil, Eric
    Wang, Xiaodong
    Graham, Douglas
    Frye, Stephen
    Earp, H. Shelton
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [9] Endothelial Inflammatory Signaling Suppresses MDSC-Mediated Pulmonary Vascular Remodeling
    Bryant, A. J.
    Fu, C.
    Lu, Y.
    Williams, M.
    Brantly, M.
    Scott, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis
    Ryan J. King
    Surendra K. Shukla
    Chunbo He
    Enza Vernucci
    Ravi Thakur
    Kuldeep S. Attri
    Aneesha Dasgupta
    Nina V. Chaika
    Scott E. Mulder
    Jaime Abrego
    Divya Murthy
    Venugopal Gunda
    Camila G. Pacheco
    Paul M. Grandgenett
    Audrey J. Lazenby
    Michael A. Hollingsworth
    Fang Yu
    Kamiya Mehla
    Pankaj K. Singh
    Oncogene, 2022, 41 : 971 - 982